Form D · Pharmaceuticals
Resilience Therapeutics, Inc.
Duxbury, MA · CIK 0001630938
Offering snapshot reported Mar 3, 2016 · SEC filing
- Reported sold
- $500K Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 24, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2016 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jul 30, 2015 | Amendment | $2,915,000 | $1,990,000vs Jan 21, 2015 | 32 | SEC filing |
| Jun 30, 2015 | Amendment | $2,715,000 | $1,790,000vs Jan 21, 2015 | 29 | SEC filing |
| Mar 9, 2015 | Amendment | $1,325,000 | $400,000vs Jan 21, 2015 | 18 | SEC filing |
| Jan 21, 2015 | Initial | $925,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-258548
Source: Form D, filed Mar 3, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William M Cowan | Director |
| Jason E Fuller | Director |
| Restina M Meyer | Executive |
| Retsina M Meyer | Executive |
| Jeffrey R Sabados | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
536 Bay Road
Duxbury, MA, 02332
Duxbury, MA, 02332